🔎 Trials Near Me

Akèy › Twoub san › Texas › Houston

Etid klinik pou Twoub san nan Houston, TX

9 etid pou Twoub san ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

Ap rekriteFaz 3
  • Texas Childrens Cancer and Hematology Center, Houston
  • U of TX Health Science Ct, Houston
Laj 12 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT06439082

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

Ap rekriteFaz 3
  • Quetzal Site 6, Houston
Laj 18 a 71 · Tout sèks · Mizajou Sep 23, 2026 · NCT07504458

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Ap rekriteFaz 3
  • Baylor College of Medicine, Houston
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT06722235

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Ap rekriteFaz 2
  • The University of Texas MD Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT04996875

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Ap rekriteFaz 3
  • Baylor College of Medicine, Houston
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06948318

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

Ap rekriteEtid obsèvasyon
  • Gulf States Hemophilia and Thrombophilia Center, Houston
  • Texas Children's Hemophilia & Thrombosis Center/Baylor College of Medicine, Houston
Tout laj · Tout sèks · Mizajou Aug 17, 2026 · NCT04398628

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Ap rekriteFaz 2/3
  • MD Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou Apr 30, 2026 · NCT04256317

Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs

Ap rekriteFaz 1
  • The University of Texas MD Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou Apr 13, 2025 · NCT05423691

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

Ap rekriteFaz 1
  • MD Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou Nov 15, 2024 · NCT06034275

Etid Twoub san nan lòt vil

Lòt etid nan Houston

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.